Limagrain and Qi Biodesign sign worldwide licensing agreement for genome editing technologies to accelerate the development of next-generation crop varietiesLimagrain and leading genome editing player Beijing Qi Biodesign Biotechnology Co., Ltd. ("Qi Biodesign") today announced a global licensing agreement granting Limagrain access to a portfolio of genome editing technologies for field and vegetable crops. This collaboration agreement marks a new milestone in Limagrain’s strategy to expand into next-generation breeding technologies and reinforce its leadership in crop innovation.
